Cargando…
Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab
Borrelia-specific antibodies in serum did not contribute to the diagnosis of Borrelia arthritis or Borrelia-associated dermatitis in a young woman with ongoing treatment with rituximab due to multiple sclerosis. The diagnosis was confirmed by the detection of Borrelia-DNA in a skin punch biopsy. The...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907593/ https://www.ncbi.nlm.nih.gov/pubmed/33643217 http://dx.doi.org/10.3389/fneur.2021.645298 |
_version_ | 1783655530173038592 |
---|---|
author | Sjöwall, Johanna Xirotagaros, Georgios Anderson, Chris D. Sjöwall, Christopher Dahle, Charlotte |
author_facet | Sjöwall, Johanna Xirotagaros, Georgios Anderson, Chris D. Sjöwall, Christopher Dahle, Charlotte |
author_sort | Sjöwall, Johanna |
collection | PubMed |
description | Borrelia-specific antibodies in serum did not contribute to the diagnosis of Borrelia arthritis or Borrelia-associated dermatitis in a young woman with ongoing treatment with rituximab due to multiple sclerosis. The diagnosis was confirmed by the detection of Borrelia-DNA in a skin punch biopsy. The patient history did not reveal any tick exposure. She had suffered for several months from fluctuating pain and swelling of the right knee as well as skin involvement with redness and oedema around the ankle of the same leg. Monoarthritis was confirmed by a rheumatologist. Knee puncture was performed but the synovial fluid was only sufficient for microscopic examination of crystals. Neither monosodium urate crystals nor calcium pyrophosphate crystals were found. Borrelia serology in blood revealed borderline levels of immunoglobulin (Ig)M and IgG, respectively. Treatment with doxycycline resulted in resolution of the joint and skin manifestations within a month. This case highlights that Borrelia-specific antibody levels cannot be reliably interpreted in patients who have received B-cell depleting therapy. Under these circumstances, detection of the bacterial genome in different body fluids, such as in the skin, can be a useful complement to the diagnosis of Lyme disease. In this young female, the diagnosis would certainly have been further delayed without the detection of Borrelia-DNA in the skin. |
format | Online Article Text |
id | pubmed-7907593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79075932021-02-27 Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab Sjöwall, Johanna Xirotagaros, Georgios Anderson, Chris D. Sjöwall, Christopher Dahle, Charlotte Front Neurol Neurology Borrelia-specific antibodies in serum did not contribute to the diagnosis of Borrelia arthritis or Borrelia-associated dermatitis in a young woman with ongoing treatment with rituximab due to multiple sclerosis. The diagnosis was confirmed by the detection of Borrelia-DNA in a skin punch biopsy. The patient history did not reveal any tick exposure. She had suffered for several months from fluctuating pain and swelling of the right knee as well as skin involvement with redness and oedema around the ankle of the same leg. Monoarthritis was confirmed by a rheumatologist. Knee puncture was performed but the synovial fluid was only sufficient for microscopic examination of crystals. Neither monosodium urate crystals nor calcium pyrophosphate crystals were found. Borrelia serology in blood revealed borderline levels of immunoglobulin (Ig)M and IgG, respectively. Treatment with doxycycline resulted in resolution of the joint and skin manifestations within a month. This case highlights that Borrelia-specific antibody levels cannot be reliably interpreted in patients who have received B-cell depleting therapy. Under these circumstances, detection of the bacterial genome in different body fluids, such as in the skin, can be a useful complement to the diagnosis of Lyme disease. In this young female, the diagnosis would certainly have been further delayed without the detection of Borrelia-DNA in the skin. Frontiers Media S.A. 2021-02-12 /pmc/articles/PMC7907593/ /pubmed/33643217 http://dx.doi.org/10.3389/fneur.2021.645298 Text en Copyright © 2021 Sjöwall, Xirotagaros, Anderson, Sjöwall and Dahle. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Sjöwall, Johanna Xirotagaros, Georgios Anderson, Chris D. Sjöwall, Christopher Dahle, Charlotte Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab |
title | Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab |
title_full | Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab |
title_fullStr | Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab |
title_full_unstemmed | Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab |
title_short | Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab |
title_sort | case report: borrelia-dna revealed the cause of arthritis and dermatitis during treatment with rituximab |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907593/ https://www.ncbi.nlm.nih.gov/pubmed/33643217 http://dx.doi.org/10.3389/fneur.2021.645298 |
work_keys_str_mv | AT sjowalljohanna casereportborreliadnarevealedthecauseofarthritisanddermatitisduringtreatmentwithrituximab AT xirotagarosgeorgios casereportborreliadnarevealedthecauseofarthritisanddermatitisduringtreatmentwithrituximab AT andersonchrisd casereportborreliadnarevealedthecauseofarthritisanddermatitisduringtreatmentwithrituximab AT sjowallchristopher casereportborreliadnarevealedthecauseofarthritisanddermatitisduringtreatmentwithrituximab AT dahlecharlotte casereportborreliadnarevealedthecauseofarthritisanddermatitisduringtreatmentwithrituximab |